Japan's Shionogi to buy Torii Pharmaceutical for $1 billion, Nikkei says

Published on 07/05/2025 at 06:30

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Shionogi & Co., Ltd.

ViiV expands licence to allow generic HIV treatment production for low-income countries	07-14	RE
Shionogi & Co., Ltd. Implements Stibo Systems MDM Solution	07-10	CI
Stallergenes Greer, Shionogi & Co., Ltd. and Ceolia Pharma Co. Ltd Announces the Transition of Promotional Activities for Actair®? in Japan	07-03	CI
Correction: BioVersys to Collaborate With Japan's Shionogi on Novel Ansamycin Leads	07-02	MT
BioVersys AG and Shionogi & Co., Ltd Enters into Global Research Collaboration for Broad-Spectrum Non-Tuberculous Mycobacteria Clinical Candidate	07-02	CI
BioVersys to Collaborate With Japan's Shionogi on Novel Ansamycin Leads	07-02	MT
Shionogi & Co., Ltd. Submits Supplemental New Drug Application for Ensitrelvir in Japan for the Treatment of COVID-19 in Pediatric Patients Aged 6 Years and Older	06-30	CI
Shionogi Seeks Japan Approval to Expand COVID-19 Drug Ensitrelvir for Pediatric Use	06-30	MT
Shionogi Completes Tender Offer for Torii Pharmaceutical, Acquiring 39% Stake	06-19	MT
Shionogi & Co., Ltd. completed the acquisition of 44.1% stake in Torii Pharmaceutical Co., Ltd. from group of sellers.	06-17	CI
Japan Shares Fall as Tokyo Inflation Hits Two-Year High	05-30	MT
Shionogi & Co., Ltd. Announces Acceptance of New Drug Application for Naldemedine tosilate in China	05-30	CI
Shionogi's Opioid-Induced Constipation Drug Accepted for Review in China	05-30	MT
Shionogi & Co Ltd - Acceptance Of A New Drug Application For Naldemedine, A Treatment For Opioid-Induced Constipation, In China	05-30	RE
Shionogi & Co., Ltd. and Veritas in Silico Inc. Announce Milestone Achievement in Joint Drug Discovery Research of mRNA -Targeted Small Molecules	05-23	CI
Shionogi & Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2025 and for the Year Ending March 31, 2026	05-12	CI
Japan's Nikkei ends higher; NTT Data surges on takeover report	05-08	RE
Japan's Nikkei rises; NTT Data set to surge on takeover report	05-08	RE
Shionogi to Acquire Japan Tobacco's Pharma Business, Take Full Control of Torii Pharmaceutical	05-07	MT
Deals of the day-Mergers and acquisitions	05-07	RE
Deals of the day-Mergers and acquisitions	05-07	RE
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion	05-07	RE
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion	05-07	RE
Japan's Nikkei snaps 7-day winning streak as US tariff worries weigh	05-07	RE
Shionogi & Co: To Launch Tender Offer For Torii Pharmaceutical Shares At 6,350 Yen Per Share	05-07	RE